Protective Effect of Mangafodipir Against Oxaliplatin Neurotoxicity

NCT00727922 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Neurotoxic Disorders
Cancer

Interventions

DRUG: Mangafodipir

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]